UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028641
Receipt number R000032781
Scientific Title Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication
Date of disclosure of the study information 2017/09/22
Last modified on 2024/02/15 09:27:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication

Acronym

Mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication

Scientific Title

Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication

Scientific Title:Acronym

Mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication

Region

Japan


Condition

Condition

gastric cancer after successful eradication

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify mucosal barrier damage due to factors of gastric juice after eradication

Basic objectives2

Others

Basic objectives -Others

To clarify difference in mucosal barrier dysfunction caused by acetaldehyde or paptideglycan

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Difference in mucosal barrier dysfunction caused by acetaldehyde or peptideglycan

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

endoscopic biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

patients with follow-up endoscopic examination after ESD for post-eradication gastric cancer

Key exclusion criteria

1. contraindication for endoscoic biopsy
2. patients who take NSAIDs, steroid, or immunosuppressive medication
3. patients treated by surgecy for upper GI tract
4. patients who take antibiotics in 12 months
5. pregnancy
6. severe general condition or phycological dysorder
7. inappropriate for enrolling this trial

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kaname
Middle name
Last name Uno

Organization

Tohoku university

Division name

Gastroenterology

Zip code

981-8574

Address

1-1 Seiryo-cho Aoba-ku Sendai, Miyagi, Japan

TEL

022-717-7171

Email

kaname-1@umin.ac.jp


Public contact

Name of contact person

1st name Kaname
Middle name
Last name Uno

Organization

Tohoku university

Division name

Gastroenterology

Zip code

981-8574

Address

1-1 Seiryo-cho, aobaku, Sendai, Miyagi, Japan

TEL

022-717-7171

Homepage URL


Email

kaname-1@umin.ac.jp


Sponsor or person

Institute

Tohoku university

Institute

Department

Personal name



Funding Source

Organization

Tohoku univerisity

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tohoku University Hospital IRB

Address

1-1 Seiryo-cho Aoba-ku Sendai Miyagi

Tel

022-728-4105

Email

office@nrs.hosp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 22 Day


Related information

URL releasing protocol

https://pubmed.ncbi.nlm.nih.gov/37943385/

Publication of results

Partially published


Result

URL related to results and publications

https://pubmed.ncbi.nlm.nih.gov/37943385/

Number of participants that the trial has enrolled

40

Results

Methods: To evaluate barrier function of background mucosa against the stimulations, we applied biopsy samples from 76 patients on mini-Ussing chamber system and immunohistochemical study.
Results: In the UCs, Pg. lipopolysaccharide reduced the impedance of metaplastic and inflamed mucosa with increases in mRNA expression of toll-like receptor 2, tumor necrosis factor, and apoptotic markers.

Results date posted

2024 Year 02 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Forty patients with GC detected at least 2 years after successful H. pylori eradication therapy (post-eradication GC), who visited our department between June 2019 and November 2020, were enrolled in this study.

Participant flow

Under endoscopic inspection, three biopsy samples were obtained from background mucosa suffering from GC, and they were separately applied to histological studies, a mini-Ussing chamber system (mUCs), and molecular biological studies.

Adverse events

none

Outcome measures

biopsy samples to mUCs to evaluate changes in the mucosal barrier function by external stimulations
The degree of inflammation, activity, atrophy, and metaplasia of endoscopic biopsy specimens was evaluated based on the uSS

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 08 Month 11 Day

Date of IRB

2017 Year 09 Month 22 Day

Anticipated trial start date

2017 Year 10 Month 01 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 11 Day

Last modified on

2024 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032781


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name